Staffing cuts across the US Food and Drug Administration related to the Department of Government Efficiency (DOGE) initiatives will undoubtedly shake up the Office of Cosmetics and Colors (OCAC) and delay implementation of cosmetics reform regulation, says EAS Consulting Group’s John Bailey.
FDA Cosmetics Office Braces For Agency-Wide Staff Cuts; MoCRA Implementation Likely Delayed
The Trump Administration Department of Government Efficiency’s staff cuts within FDA will “most certainly” impact the Office of Cosmetics and Colors and delay the implementation of the Modernization of Cosmetics Regulation Act, says EAS Consulting Group’s John Bailey.
More from Policy & Regulation
More from HBW Insight
• By
Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.